Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 50 for “"Biologic therapy"”.

  1. Biologic therapy in patients with autoimmune arthritis /

    Biological drugs (BD) have been used in the treatment of autoimmune arthritis (AA) for over 15 years. In spite of the many randomized clinical trials on BD, there is a lack of data on the special aspects of long-term application in everyday rheumatology clinical practice; for this reason the aim of …

    vilnius Repository record for Biologic therapy in patients with autoimmune arthritis / (opens in a new tab)

  2. Serial fecal biomarker measurements predict response to biologic therapy in children with IBD

    … of noninvasive methods of assessing response to therapy is of increasing importance to pediatric healthcare providers. Previous studies have demonstrated that serum and fecal biomarkers are reliable measures of inflammation in the gastrointestinal tract. However, existing biomarkers are …

    bu Repository record for Serial fecal biomarker measurements predict response to biologic therapy in children with IBD (opens in a new tab)

  3. Evaluating ultrasound confirmed enthesitis as a predictive marker for response to biologic therapy in psoriatic arthritis

    … range of effective treatments, in particular the biologic agents for moderate to severe disease. There is however no effective biomarkers that can predict response or allow us to decide between biologic treatments based on the musculoskeletal manifestations of psoriatic disease.<br/><br/>An …

    qu-belfast Repository record for Evaluating ultrasound confirmed enthesitis as a predictive marker for response to biologic therapy in psoriatic arthritis (opens in a new tab) Download PDF for Evaluating ultrasound confirmed enthesitis as a predictive marker for response to biologic therapy in psoriatic arthritis (opens in a new tab)

  4. Structural and Functional Relevance of Intraluminal Mucus in Severe Asthma: Persistence During Biologic Therapy and Response to TSLP Blockade

    … and contributes to airflow obstruction. Biologic therapies targeting type-2 (T2) inflammation can reduce MP, but the extent and clinical relevance of residual MP during treatment remain unclear. Tezepelumab, an anti-TSLP biologic, has been reported to reduce MP; however, its impact on …

    mcmaster Repository record for Structural and Functional Relevance of Intraluminal Mucus in Severe Asthma: Persistence During Biologic Therapy and Response to TSLP Blockade (opens in a new tab)

  5. Artificial intelligence in medicine: a clinical decision-support framework based on machine learning, statistical mixed-effect modeling and defeasible reasoning for rheumatoid arthritis long-term prognosis under biologic therapy

    … (RA) management and long-term prognosis under biologic therapy. The CDS-RA utilizes artificial intelligence methods to conduct advanced medical data analyses based on statistical mixed-effect models, machine learning and defeasible reasoning. An important objective of the CDS-RA is to provide …

    greece Repository record for Artificial intelligence in medicine: a clinical decision-support framework based on machine learning, statistical mixed-effect modeling and defeasible reasoning for rheumatoid arthritis long-term prognosis under biologic therapy (opens in a new tab)

  6. Effect of therapeutic interventions on skeletal growth & development in paediatric inflammatory bowel disease

    … number of different mechanisms including steroid therapy, the disease process, nutritional status, endocrine status and the response of the body to inflammatory mediators. The recent introduction of biologic therapy that targets specific mediators of the proinflammatory process is a promising …

    glasgow Download PDF for Effect of therapeutic interventions on skeletal growth & development in paediatric inflammatory bowel disease (opens in a new tab)

  7. A Novel Approach for Integrating Best Evidence and Patient Preferences into Treatment Recommendations for Rheumatoid Arthritis

    … in our population (78%) would prefer triple therapy (the combination of methotrexate, sulphasalazine and hydroxychloroquine) to methotrexate alone as initial therapy, suggesting a relatively strong recommendation could be made. In patients who have had an inadequate response to methotrexate, …

    toronto-retro Repository record for A Novel Approach for Integrating Best Evidence and Patient Preferences into Treatment Recommendations for Rheumatoid Arthritis (opens in a new tab)

  8. Μελέτη της επίδρασης των θεραπειών έναντι των ιδιοπαθών φλεγμονωδών νοσημάτων του εντέρου στην ακεραιότητα του βλεννογονικού φραγμού

    … included IBD-related surgery, initiation of biologic therapy, and clinical relapse. Logistic regression and Cox proportional hazards models were used to evaluate clinical outcomes. Longitudinal changes were assessed in 127 patients with available baseline and follow-up biopsies.Results: Both …

    greece Repository record for Μελέτη της επίδρασης των θεραπειών έναντι των ιδιοπαθών φλεγμονωδών νοσημάτων του εντέρου στην ακεραιότητα του βλεννογονικού φραγμού (opens in a new tab)

  9. Segmented and total direct cost-of-care for advanced squamous cell carcinoma of the head and neck in a privately insured population

    … SCCHN include the use of combined modality therapy (e.g., radiation plus chemotherapy/biologic therapy). The new biologic agent, cetuximab, is considered a primary cost driver for SCCHN management. Cetuximab’s impact, however, has not been factored into SCCHN cost estimates; furthermore, …

    texas Repository record for Segmented and total direct cost-of-care for advanced squamous cell carcinoma of the head and neck in a privately insured population (opens in a new tab)

  10. Surgery for inflammatory bowel disease in the era of advanced medical therapy

    … IBD has classically involved the use of medical therapy to induce and maintain remission with surgery reserved for disease that is refractory to medical therapy or where irreversible complications have occurred. Treatment was historically limited to corticosteroids and immunomodulators such as …

    edinburgh Repository record for Surgery for inflammatory bowel disease in the era of advanced medical therapy (opens in a new tab)

  11. Long-term outcomes of immunosuppression - naïve steroid responders following hospitalization for acute severe ulcerative colitis

    … respond to the initial intravenous steroid therapy receive medical rescue therapy with infliximab or cyclosporine or undergo surgery for their refractory disease. However, there is limited guidance on management of steroid responders in this setting. While it is well established that Crohn’s …

    bu Repository record for Long-term outcomes of immunosuppression - naïve steroid responders following hospitalization for acute severe ulcerative colitis (opens in a new tab)

  12. DEVELOPMENT OF PROTEIN-BASED ANTIFUNGALS

    … their own shortcomings. The field of antifungal biologic therapy is relatively unexplored given the orphan status of invasive mycosis. Antifungal biologics offer the possibility of treating invasive mycosis both in systemic and tissue infections without the associated limitations facing …

    nus Repository record for DEVELOPMENT OF PROTEIN-BASED ANTIFUNGALS (opens in a new tab) Download file for DEVELOPMENT OF PROTEIN-BASED ANTIFUNGALS (opens in a new tab)

  13. Psoriatic Arthritis Screening: A Systematic Review, Meta-Analysis, and Economic Evaluation

    … treatment costs later on. Although expensive biologic therapy has proven to slow disease progression and improve health outcomes, rheumatologists have suggested initiating treatment with less expensive Disease Modifying Anti-Rheumatic Drugs (DMARDs). Identifying early PsA is expected to …

    calgary Repository record for Psoriatic Arthritis Screening: A Systematic Review, Meta-Analysis, and Economic Evaluation (opens in a new tab)

  14. Comparative Effectiveness and Molecular Profiling of Dupilumab Versus Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps (CRSWNP)

    … from surgical intervention to targeted biologic immunomodulation. Endoscopic sinus surgery (ESS) remains a cornerstone therapy for restoring sinus ventilation and topical drug delivery; however, recurrence rates remain high, particularly in patients with asthma or aspirin-exacerbated …

    arizona-thes Repository record for Comparative Effectiveness and Molecular Profiling of Dupilumab Versus Endoscopic Sinus Surgery in Chronic Rhinosinusitis With Nasal Polyps (CRSWNP) (opens in a new tab)

  15. Investigation of novel CD1a-lipid antigen presentation pathways in the skin

    … those under treatment with ultraviolet phototherapy or the anti-IL-17A biologic therapy secukinumab), atopic dermatitis and healthy controls. The findings were integrated with public datasets and were validated using imaging mass cytometry at the protein level. These data, alongside clinical …

    oxford Repository record for Investigation of novel CD1a-lipid antigen presentation pathways in the skin (opens in a new tab)

  16. Avaliação do perfil clínico e epidemiológico de pacientes em uso do dupilumabe no controle da dermatite atópica moderada a grave

    … quality of life. Dupilumab is the first biologic therapy approved in Brazil for the treatment of moderate to severe AD. Objectives: To characterize the sociodemographic and clinical profile, as well as disease severity, of the participants. To evaluate the progression of clinical scores …

    brazil-uerj Repository record for Avaliação do perfil clínico e epidemiológico de pacientes em uso do dupilumabe no controle da dermatite atópica moderada a grave (opens in a new tab)

  17. Šiuolaikinis uždegiminių žarnų ligų gydymas. Indikacijos, kontraindikacijos biologinei terapijai, jos sukeliamos komplikacijos /

    … contraindications and complications of biological therapy for inflammatory bowel disease that are commonly reported in the scientific literature. Review of the literature: The selection for scientific publications was made from 2024 01 16 to 2024 03 20. Scientific publications were …

    vilnius Repository record for Šiuolaikinis uždegiminių žarnų ligų gydymas. Indikacijos, kontraindikacijos biologinei terapijai, jos sukeliamos komplikacijos / (opens in a new tab)

  18. Improving outcome for people with chronic widespread pain and fibromyalgia

    … such patients do (as a group) respond to biologic therapy but that specific aspects of their conditions (high somatic symptom burden) predict non-response and the likely need for additional (non-pharmacologic approaches) to management.

    glasgow Repository record for Improving outcome for people with chronic widespread pain and fibromyalgia (opens in a new tab) Download PDF for Improving outcome for people with chronic widespread pain and fibromyalgia (opens in a new tab)

  19. Characterising disease heterogeneity in Crohn's disease and ulcerative colitis: leveraging longitudinal biomarker profiles

    … associated with smoking (p = 0.015) and early biologic therapy (p < .001) and is unable to be independently predicted using traditional clinical approaches to disease classification. Whilst I find the approach feasible, the study cohort in the pilot study was restricted in size (n = 356) and …

    edinburgh Repository record for Characterising disease heterogeneity in Crohn's disease and ulcerative colitis: leveraging longitudinal biomarker profiles (opens in a new tab)

Page 1 of 3